Overexpression of P53 in head and neck cancer

Head & Neck

Volumn 14, Issue 6, 1992, Pages 437-444

  Watling, David L ^a   Gown, Allen M ^a   Coltrera, Marc D ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P53; TUMOR MARKER;

ARTERIOVENOUS MALFORMATION; CANCER GRADING; CARCINOGENESIS; CELL GROWTH; CHORDOMA; CONFERENCE PAPER; CYSTADENOCARCINOMA; GENE EXPRESSION; HEAD TUMOR; HEMANGIOFIBROMA; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MUTATION; NECK TUMOR; PAPILLOMA; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE; VIRUS ONCOGENE;

ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HEAD AND NECK NEOPLASMS; HUMAN; PROGNOSIS; PROSPECTIVE STUDIES; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0026768143     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.2880140603     Document Type: Article

References (32)

1. A genetic model for colorectal tumorigenesis
2. Genetic and cellular basis of multistep carcinogenesis
3. Tumor suppressor genes
4. The p53 tumour suppressor gene
5. Cancer. A deadly inheritance
6. Mutant p53 — the commonest genetic abnormality in human cancer?
7. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53
8. Activating mutations for transformation by p53 produce a gene product that forms an hsc 70‐p53 complex with an altered half‐life
9. Monoclonal antibody analysis of p53 expression in normal and transformed cells
10. Isolation of human‐p53‐specific monoclonal antibodies and their use in the study of human p53 expression
11. p53 expression in breast cancer
12. Increased expression of mutant forms of p53 oncogene in primary lung cancer
13. T antigen is bound to a host protein in SV40‐transformed cells
14. Adenovirus E1b‐58kD antigen binds to p53 during infection of rodent cells: evidence for an N‐terminal binding site on p53
15. Analysis of proliferative grade using anti‐PCNA/cyclin monoclonal antibodies in fixed, embedded tissues
16. Widespread p53 overexpression in human malignant tumors—an immunohistochemical study using methacarnfixed, embedded tissue
17. Histologic classification and grading of malignancy in carcinoma of the larynx
18. Prognostic factors in head and neck cancer: histologic grading, DNA ploidy, and nodal status
19. Tumor suppressor genes: a new arena in the war against cancer
20. Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products
21. Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation
22. The p53 proto‐oncogene can act as a suppressor of transformation
23. Wild‐type p53 can inhibit oncogene‐mediated focus formation
24. Suppression of human colorectal carcinoma cell growth by wild‐type p53
25. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
26. Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines
27. Frequent mutations in the p53 tumor suppressor gene in human leukemia T‐cell lines
28. Mechanisms of p53 loss in human sarcomas
29. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
30. p53 mutations in colorectal cancer
31. Complex alterations to cell cycle regulation mediated by HPV 16 oncoproteins in organotypic culture
32. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer